Malignant pleural mesothelioma is an aggressive malignancy of the pleural surface,
predominantly caused by prior asbestos exposure. There is a global epidemic of malignant …

Malignant mesothelioma is an aggressive tumor of serosal surfaces, such as the pleura and
the peritoneum. This tumor was once rare, but its incidence is increasing worldwide …

Background VTE is a common cause of preventable death in surgical patients. Methods We
developed recommendations for thromboprophylaxis in nonorthopedic surgical patients by …

This article discusses the prevention of venous thromboembolism (VTE) and is part of the
Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence …

Background The effects of extra-pleural pneumonectomy (EPP) on survival and quality of life
in patients with malignant pleural mesothelioma have, to our knowledge, not been assessed …

Malignant pleural mesothelioma (MPM) is a rare tumour but with increasing incidence and a
poor prognosis. In 2008, the European Respiratory Society/European Society of Thoracic …

Malignant mesothelioma is an aggressive, treatment-resistant tumour, which is increasing in
frequency throughout the world. Although the main risk factor is asbestos exposure, a virus …

Malignant pleural mesothelioma (MPM) is a deadly disease that occurs in 2,000 to 3,000
people each year in the United States. Although MPM is an extremely difficult disease to …

Purpose This multicenter, phase II clinical study was conducted to evaluate the activity of the
combination of pemetrexed and carboplatin in patients with malignant pleural mesothelioma …

Background: The aim of this multicenter trial was to prospectively evaluate neo-adjuvant
chemotherapy followed by extrapleural pneumonectomy (EPP) and radiotherapy, including …